Unresolved disorder model. using A ATOM 821 CA AHIS 107 -13.617 -5.336 10.589 0.50 16.00 C Unresolved disorder model. using A ATOM 822 CA BHIS 107 -13.634 -5.438 10.593 0.50 15.85 C Unresolved disorder model. using A ATOM 825 CB AHIS 107 -12.998 -4.134 11.308 0.50 16.48 C Unresolved disorder model. using A ATOM 826 CB BHIS 107 -12.942 -4.489 11.594 0.50 16.03 C Unresolved disorder model. using A ATOM 827 CG AHIS 107 -11.881 -4.478 12.236 0.50 16.95 C Unresolved disorder model. using A ATOM 828 CG BHIS 107 -13.710 -4.278 12.865 0.50 16.48 C Unresolved disorder model. using A ATOM 829 ND1AHIS 107 -12.090 -5.093 13.453 0.50 18.80 N Unresolved disorder model. using A ATOM 830 ND1BHIS 107 -14.089 -5.316 13.691 0.50 15.85 N Unresolved disorder model. using A ATOM 831 CD2AHIS 107 -10.548 -4.242 12.154 0.50 18.94 C Unresolved disorder model. using A ATOM 832 CD2BHIS 107 -14.165 -3.145 13.453 0.50 17.01 C Unresolved disorder model. using A ATOM 833 CE1AHIS 107 -10.929 -5.248 14.068 0.50 18.75 C Unresolved disorder model. using A ATOM 834 CE1BHIS 107 -14.754 -4.833 14.726 0.50 17.10 C Unresolved disorder model. using A ATOM 835 NE2AHIS 107 -9.979 -4.737 13.305 0.50 18.92 N Unresolved disorder model. using A ATOM 836 NE2BHIS 107 -14.806 -3.517 14.611 0.50 17.33 N Unresolved disorder model. using A ATOM 1472 CA ATRP 197 -9.491 16.826 -16.965 0.50 29.06 C Unresolved disorder model. using A ATOM 1473 CA BTRP 197 -9.492 16.812 -17.044 0.50 29.00 C Unresolved disorder model. using A ATOM 1476 CB ATRP 197 -9.232 17.672 -15.722 0.50 28.67 C Unresolved disorder model. using A ATOM 1477 CB BTRP 197 -9.113 17.842 -15.972 0.50 28.56 C Unresolved disorder model. using A ATOM 1478 CG ATRP 197 -8.557 18.991 -15.927 0.50 28.43 C Unresolved disorder model. using A ATOM 1479 CG BTRP 197 -9.633 19.275 -16.149 0.50 28.65 C Unresolved disorder model. using A ATOM 1480 CD1ATRP 197 -7.223 19.215 -16.037 0.50 27.81 C Unresolved disorder model. using A ATOM 1481 CD1BTRP 197 -9.417 20.319 -15.290 0.50 28.65 C Unresolved disorder model. using A ATOM 1482 CD2ATRP 197 -9.189 20.281 -15.987 0.50 28.73 C Unresolved disorder model. using A ATOM 1483 CD2BTRP 197 -10.457 19.805 -17.207 0.50 28.02 C Unresolved disorder model. using A ATOM 1484 NE1ATRP 197 -6.981 20.558 -16.180 0.50 28.81 N Unresolved disorder model. using A ATOM 1485 NE1BTRP 197 -10.033 21.457 -15.748 0.50 27.83 N Unresolved disorder model. using A ATOM 1486 CE2ATRP 197 -8.168 21.236 -16.153 0.50 28.55 C Unresolved disorder model. using A ATOM 1487 CE2BTRP 197 -10.682 21.171 -16.917 0.50 27.20 C Unresolved disorder model. using A ATOM 1488 CE3ATRP 197 -10.522 20.719 -15.929 0.50 28.53 C Unresolved disorder model. using A ATOM 1489 CE3BTRP 197 -11.018 19.267 -18.368 0.50 28.04 C Unresolved disorder model. using A ATOM 1490 CZ2ATRP 197 -8.433 22.611 -16.257 0.50 28.94 C Unresolved disorder model. using A ATOM 1491 CZ2BTRP 197 -11.437 21.999 -17.744 0.50 27.57 C Unresolved disorder model. using A ATOM 1492 CZ3ATRP 197 -10.786 22.085 -16.033 0.50 28.53 C Unresolved disorder model. using A ATOM 1493 CZ3BTRP 197 -11.768 20.097 -19.190 0.50 28.07 C Unresolved disorder model. using A ATOM 1494 CH2ATRP 197 -9.747 23.011 -16.193 0.50 28.07 C Unresolved disorder model. using A ATOM 1495 CH2BTRP 197 -11.966 21.447 -18.874 0.50 28.37 C 1